1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Cancer
  5. Bladder cancer

Sacituzumab govitecan for treating unresectable metastatic urothelial cancer [ID6150]

In development [GID-TA11009] Expected publication date: TBC

  • Project information
  • Project documents

29329-Sacituzumab-Govitecan-for-Urothelial-Cancer-V1.0-FEB2022-NON-CONF.pdf (nihr.ac.uk)